Phase 1 BA Study, Single Center With Healthy Volunteers

Single dose in healthy volunteers to assess bioavailability (amount of study drug in the system) between different formulations of ABT-874.

Inclusion Criteria:

• Subjects must be healthy

Exclusion Criteria:

• Subjects who are not healthy, enrolled in another study, or who have received ABT-874 previously.